Patents by Inventor Daniel Knopp

Daniel Knopp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vaccine against
    Patent number: 11891413
    Abstract: The present invention relates to a synthetic oligosaccharide of general formula (I): T*-[(—Ux+4—Ux+3—Ux+2—Ux+1—Ux)m—(Vx+2—Vx+1—Vx)1-m-T-O-L-E that is related to Klebsiella pneumoniae serotype O3, O3b and/or O5 lipopolysaccharide and conjugate thereof. Said synthetic oligosaccharide, said conjugate and pharmaceutical composition containing said synthetic oligosaccharide or said conjugate are useful for prevention and/or treatment of diseases associated with Klebsiella pneumoniae. Furthermore, the synthetic oligosaccharide of general formula (I) is useful as marker in immunological assays for detection of antibodies against Klebsiella pneumoniae serotype O3, O3b and/or O5 bacteria.
    Type: Grant
    Filed: November 30, 2018
    Date of Patent: February 6, 2024
    Assignee: IDORSIA PHARMACEUTICALS LTD
    Inventors: Arun Naini, Daniel Knopp, Bopanna Monnanda, Arne Von Bonin, Claney Lebev Pereira
  • STABLE VACCINE AGAINST CLOSTRIDIUM DIFFICILE
    Publication number: 20230045939
    Abstract: The present invention relates to a synthetic saccharide of general formulate (I) that is related to Clostridium difficile PS-II cell-surface polysaccharide and conjugate thereof. Said synthetic saccharide, said conjugate and pharmaceutical composition containing said synthetic saccharide or said conjugate are useful for prevention and/or treatment of diseases associated with Clostridium difficile. Furthermore, the synthetic saccharide of general formula (I) is useful as marker in immunological assays for detection of antibodies against Clostridium difficile bacteria.
    Type: Application
    Filed: November 22, 2019
    Publication date: February 16, 2023
    Inventors: Madhu EMMADI, Marilda P. LISBOA, Daniel KNOPP, Bopanna MONNANDA, Arne VON BONIN, Claney Lebev PEREIRA
  • VACCINE AGAINST KLEBSIELLA PNEUMONIAE
    Publication number: 20210386845
    Abstract: The present invention relates to a synthetic oligosaccharide of general formula (I): T*-[(—Ux+4—Ux+3—Ux+2—Ux+1—Ux)m—(Vx+2—Vx+1—Vx)1-m-T-O-L-E that is related to Klebsiella pneumoniae serotype O3, O3b and/or O5 lipopolysaccharide and conjugate thereof. Said synthetic oligosaccharide, said conjugate and pharmaceutical composition containing said synthetic oligosaccharide or said conjugate are useful for prevention and/or treatment of diseases associated with Klebsiella pneumoniae. Furthermore, the synthetic oligosaccharide of general formula (I) is useful as marker in immunological assays for detection of antibodies against Klebsiella pneumoniae serotype O3, O3b and/or O5 bacteria.
    Type: Application
    Filed: November 30, 2018
    Publication date: December 16, 2021
    Inventors: Arun Naini, Daniel Knopp, Bopanna Monnanda, Arne Von Bonin, Claney Lebev Pereira